Showing results (231-240 of 597) with videos related to

Sort By:
Pageof 60
In Vitro|July 1, 1983
Cultivation of human osteosarcoma cell lines in serum-free hormone supplemented mediumK Y Tsang, H H Fudenberg, D C Sun, et al.
The American Journal of Surgical Pathology|February 1, 1997
Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sitesJ K Chan, S Suster, B M Wenig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2008
Enhanced functionality of CD4+CD25(high)FoxP3+ regulatory T cells in the peripheral blood of patients with prostate cancerJunko Yokokawa, Vittore Cereda, Cinzia Remondo, et al.
British Journal of Cancer|July 28, 2020
The significance of highlighting the oestrogen receptor low category in breast cancerIvan K Poon, Julia Y Tsang, Joshua Li, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 3, 2019
An IL-15 Superagonist, ALT-803, Enhances Antibody-Dependent Cell-Mediated Cytotoxicity Elicited by the Monoclonal Antibody NEO-201 Against Human Carcinoma CellsMassimo Fantini, Justin M David, Hing C Wong, et al.
Critical Care Medicine|March 14, 2020
Epigenetics of SepsisAlexandra Binnie, Jennifer L Y Tsang, Pingzhao Hu, et al.
Healthcare Management Forum|February 4, 2026
Defining Health System Capacity: A Rapid ReviewHeather K O'Grady, Alexandra Leone, Sinéad McElhone, et al.
Acta Crystallographica. Section E, Structure Reports Online|January 5, 2011
3-Allyl-2-hydr-oxy-5,6,8-trimethoxy-naphthalene-1,4-dioneDominea C K Rathwell, Kit Y Tsang, Ka Wai Choi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
Identification of novel human CTL epitopes and their agonist epitopes of mesothelinJunko Yokokawa, Claudia Palena, Philip Arlen, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 14, 2020
The Monoclonal Antibody NEO-201 Enhances Natural Killer Cell Cytotoxicity Against Tumor Cells Through Blockade of the Inhibitory CEACAM5/CEACAM1 Immune Checkpoint PathwayMassimo Fantini, Justin M David, Christina M Annunziata, et al.
Pageof 60